You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
On Site Mercury Remediation via Activated Fly Ash
SBC: POLLUTION CONTROL TECHNOLOGIES, LLC Topic: NIEHSDESCRIPTION provided by applicant Mercury is one of the most harmful and toxic pollutants to humans and it is predominantly introduced into the environment in vapor form from burning fossil fuels Fossil fuel consumption results in ever higher mercury concentrations in the air water soil and ultimately in food that humans consume The EPA estimates that mercury instigated healthcare costs ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
A Universal Micromanipulation Robot for Crystallography
SBC: Square One Systems Design, Inc. Topic: N/ADESCRIPTION (provided by applicant): Process automation has become an essential element of all modern crystallography facilities. Robotic equipment allows crystals of biological macromolecules to be produced in greater numbers and rapidly mounted thus resu lting in more efficient utilization of valuable X-ray resources. The need to maximize the productivity of these resources becomes more acute wi ...
STTR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
Glycoengineered insect cells for commercial biologics manufacturing
SBC: Glycobac, LLC Topic: 300DESCRIPTION provided by applicant Therapeutic proteins or andapos biologicsandapos represent a andgt $ billion market that includes a variety of important drugs such as antibodies and hormones The clinical efficacy of many biologics is determined by their sugar structures or andapos glycansandapos Most biologics are manufactured in mammalian cells because they add human type glycans ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Microwave Technology for Superfund Site Remediation
SBC: CHA CORP. Topic: N/ADESCRIPTION (provided by applicant): The long-term objective of the proposed work is to build a commercial-scale portable microwave system that is capable of regenerating 50-kg/hrof saturated carbon. This process will also be capable of recovering solv
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
LOW RISK ILLICIT DRUG LEVEL MONITORING
SBC: CC Technology Topic: N/ADESCRIPTION (provided by applicant): The goal of the proposed research is to develop two prototype drug analyzers interfaced with automated analysis readers for low risk monitoring of illicit drug levels by Surface Enhanced Raman Immuno Assay (SERIA). The first prototype will be placed in a clinical setting. This study will include urine and saliva samples collected from clients of a juvenile ass ...
SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health -
A Novel Adherence Technology for Ophthalmic Medications
SBC: Glycobac, LLC Topic: NIGMSDESCRIPTION: Most human therapeutic glycoproteins (biologics) are manufactured using mammalian cell lines that can add the human-type glycans required for their clinical efficacy. However, mammalian cells have some serious disadvantages - it takes a longtime to establish production lines, they can contain adventitious agents, and they can produce immunogenic glycans. The baculovirus-insect cell s ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Microcontact printer for ophthalmic tissue engineering
SBC: ALCES Technology, Inc. Topic: N/ADESCRIPTION (provided by applicant): This project will demonstrate a prototype microcontact printing aligner for use in ophthalmic tissue engineering. The performance of the microcontact printing aligner will be refined and validated by experiments conducted in collaboration with the Stanford Ophthalmic Tissue Engineering Laboratory. Functioning much like traditional rubber-stamping methods, micro ...
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
N/A
SBC: CC Technology Topic: N/AN/A
SBIR Phase II 2000 Department of Health and Human ServicesNational Institutes of Health -
MICROWAVE TECHNOLOGY FOR SUPERFUND SITE REMEDIATION
SBC: CHA CORP. Topic: N/ADESCRIPTION (provided by applicant): CHA Corporation has developed a microwave-based air purification technology that can be effectively utilized to recover chemicals from soil vapors produced during hazardous site remediation without using a catalytic oxidizer. A field-ready prototype microwave treatment system will be designed, constructed, and tested in the laboratory during the first year of ...
SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health -
Constitutive oxalate-biodegrading Bacillus subtilis for kidney stones
SBC: UNLOCKED LABS INC. Topic: 400Project Summary / AbstractKidney stones (nephrolithiasis) are an extremely painful and debilitating condition. About 12% of people will experience kidney stones in their lifetime, and about 70% of those will have recurrences. The economic burden of kidney stones is estimated to exceed $5 billion per year in the USA alone. Each year, over 3 million workdays are lost in the USA due to kidney stones. ...
SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health